Katelyn J. Creasman
University of California, San Francisco(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Microtubule and mitosis dynamics, Advanced Breast Cancer Therapies, Ubiquitin and proteasome pathways, Pluripotent Stem Cells Research
Most-Cited Works
- → MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition(2012)390 cited
- → Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways(2012)74 cited
- → CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation(2015)65 cited
- → Abstract C23: Therapy of triple-negative breast tumors by targeting the MYC oncogene pathway(2009)